Comparison evaluates five leading SDK generators on language coverage, runtime type safety, dependency footprint, OpenAPI ...

The Allen Institute for AI is releasing an open-source web agent that can navigate and complete tasks in a browser — letting developers look under the hood to understand what’s happening in ways not ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Available as a part of .NET 10, which was released last November, C# 14 brings a plethora of new features and enhancements that make it easier to write efficient, high performant code. Just as we ...

OpenClaw started as a side project of a developer who wanted to make his (and others) life easier with AI assistance. Clean mailbox, control schedule, organize thoughts and hear some music while his ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

When the World Wide Web went live in the early 1990s, its founders hoped it would be a space for anyone to share information and collaborate. But today, the free and open web is shrinking. Major ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...